{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:40:33Z","timestamp":1787010033562,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:p>\n                    This case report presents an 8-year-old girl, from Fars province in Iran, diagnosed with cutaneous leishmaniasis in the form of multiple nodular, ulcerative and crusted lesions disseminated on the face, trunk and extremities. The result of direct smear of ulcers was positive for\n                    <jats:italic toggle=\"yes\">Leishmania<\/jats:italic>\n                    parasite. The patient had no immunodeficiency or relevant family history making her susceptible for disseminated cutaneous leishmaniasis. The skin lesions failed to respond to multiple treatment courses of meglumine antimoniate or amphotericin B but were successfully treated with simultaneous miltefosine and liposomal amphotericin B.\n                  <\/jats:p>","DOI":"10.1097\/inf.0000000000001741","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T12:31:50Z","timestamp":1518179510000},"page":"275-277","source":"Crossref","is-referenced-by-count":7,"title":["Successful Treatment of Disseminated Cutaneous Leishmaniasis With Liposomal Amphotericin B and Miltefosine in an Eight-year-old Girl"],"prefix":"10.1097","volume":"37","author":[{"given":"Seyedeh Sedigheh","family":"Hamzavi","sequence":"first","affiliation":[{"name":"Alborzi Clinical Microbiology Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahita","family":"Sanaei Dashti","sequence":"additional","affiliation":[{"name":"Alborzi Clinical Microbiology Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Rahim","family":"Kadivar","sequence":"additional","affiliation":[{"name":"Alborzi Clinical Microbiology Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Pouladfar","sequence":"additional","affiliation":[{"name":"Alborzi Clinical Microbiology Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahman","family":"Pourabbas","sequence":"additional","affiliation":[{"name":"Alborzi Clinical Microbiology Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230913","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0035-9203(01)90223-8","article-title":"The increase in risk factors for leishmaniasis worldwide.","volume":"95","author":"Desjeux","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R2-20230913","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence.","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"R3-20230913","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5070\/D369W8K1SB","article-title":"Ulcerated disseminated cutaneous leishmaniasis associated with vitiligo, hypothyroidism, and diabetes mellitus in a patient with Down syndrome.","volume":"10","author":"Aghaei","year":"2004","journal-title":"Dermatology online journal"},{"key":"R5-20230913","first-page":"99","article-title":"Unusual presentations of cutaneous leishmaniasis in two Iranian patients.","volume":"13","author":"Asadi-Kani","year":"2010","journal-title":"Iranian J Dermatol"},{"key":"R6-20230913","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1995-7645(13)60066-8","article-title":"Unusual presentation of disseminated cutaneous leishmaniasis due to Leishmania major: case reports of four Iranian patients.","volume":"6","author":"Hajjaran","year":"2013","journal-title":"Asian Pac J Trop Med"},{"key":"R7-20230913","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00001432-200304000-00006","article-title":"Diagnosis of cutaneous leishmaniasis.","volume":"16","author":"Vega-L\u00f3pez","year":"2003","journal-title":"Curr Opin Infect Dis"},{"key":"R9-20230913","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.ijantimicag.2010.06.023","article-title":"Leishmaniasis in the world health organization Eastern Mediterranean region.","volume":"36","author":"Postigo","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"R10-20230913","doi-asserted-by":"crossref","first-page":"37789","DOI":"10.1074\/jbc.M002149200","article-title":"The immunologically protective P-4 antigen of Leishmania amastigotes. A developmentally regulated single strand-specific nuclease associated with the endoplasmic reticulum.","volume":"275","author":"Kar","year":"2000","journal-title":"J Biol Chem"},{"key":"R11-20230913","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1590\/S0074-02762002000400001","article-title":"Some aspects of protozoan infections in immunocompromised patients\u2014a review.","volume":"97","author":"Ferreira","year":"2002","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"R12-20230913","first-page":"106","article-title":"Ocular leishmaniasis; a cause of blindness.","volume":"18","author":"Kumar","year":"1993","journal-title":"Irn J Med Sci"},{"key":"R13-20230913","first-page":"1","article-title":"Ocular leishmaniasis.","volume":"19","author":"ModarresZadeh","year":"2007","journal-title":"Iranian J Ophthalmol"},{"key":"R15-20230913","first-page":"40","article-title":"Control of the leishmaniasis.","volume":"793","year":"1990","journal-title":"WHO Tech Rep Ser"},{"key":"R16-20230913","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1517\/14728214.2012.748036","article-title":"Liposomal amphotericin B as a treatment for human leishmaniasis.","volume":"17","author":"Balasegaram","year":"2012","journal-title":"Expert Opin Emerg Drugs"},{"key":"R17-20230913","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1995-7645(12)60084-4","article-title":"Leishmaniasis: current status of available drugs and new potential drug targets.","volume":"5","author":"Singh","year":"2012","journal-title":"Asian Pac J Trop Med"},{"key":"R18-20230913","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Oral miltefosine for Indian visceral leishmaniasis.","volume":"347","author":"Sundar","year":"2002","journal-title":"N Engl J Med"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201803000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T14:11:15Z","timestamp":1694614275000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201803000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001741","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}